Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, Jakub Debski, MD, Aleksandra K. Butrym, MD, PhD, Wojciech Legiec, Marek Hus, MD, PhD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan M Zaucha, Marcin Rymko, MD, Tigran Torosian, MD, Grzegorz Charlinski, Ewa Lech-Maranda, Artur J. Jurczyszyn, MD, PhD, Halina Urbanska-Rys, Agnieszka Druzd-Sitek, PhD, Kazimierz Kuliczkowski

Blood (2013) 122 (21): 3236.

https://doi.org/10.1182/blood.V122.21.3236.3236

Published: 2013

Journal Articles

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, MD, Jakub Debski, MD, Aleksandra Butrym, MD, Wojciech Legiec, MD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan Maciej Zaucha, MD, Marcin Rymko, MD, Tigran Torosian, MD, Kazimierz Kuliczkowski

Blood (2011) 118 (21): 5125.

https://doi.org/10.1182/blood.V118.21.5125.5125

Published: 2011

Journal Articles

Cladribine Alone and in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Long-Term Follow-up of the the Polish Adult Leukemia Group (PALG CLL2) Study,

Blood (2011) 118 (21): 3915.

https://doi.org/10.1182/blood.V118.21.3915.3915

Published: 2011

Journal Articles

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

Blood (2010) 116 (21): 2138.

https://doi.org/10.1182/blood.V116.21.2138.2138

Published: 2010

Journal Articles

Overall Survival (OS) Benefit of Rituximab Based Immunochemotherapy Followed by Post-Induction Treatment in Mantle Cell Lymphoma (MCL): a Retrospective Analysis of 279 Patients Treated by Polish Lymphoma Research Group (PLRG) Centers.

Wojciech Jurczak, Michal Szymczyk, Agnieszka Giza, Monika Joks, Elzbieta Kisiel, Beata Stella-Holowiecka, Piotr Boguradzki, Tomasz Wrobel, Magdalena Sikorska, Wanda Knopinska-Posluszny, Ewa Kalinka-Warzocha, Jan Walewski, Aleksander B. Skotnicki

Blood (2009) 114 (22): 1702.

https://doi.org/10.1182/blood.V114.22.1702.1702

Published: 2009

Journal Articles

Status of Minimal Residual Disease Determines Outcome of Autologous HSCT in Adults with High-Risk Acute Lymphoblastic Leukemia.

Sebastian Giebel, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Nicola Goekbuget, Dieter Hoelzer, Michael Doubek, Jiri Mayer, Beata Piatkowska-Jakubas, Aleksander Skotnicki, Herve Dombret, Josep-Maria Ribera, Pier Paolo Piccaluga, Tomasz Czerw, Maria Sadus-Wojciechowska, Slawomira Kyrcz-Krzemien, Jerzy Holowiecki

Blood (2009) 114 (22): 2321.

https://doi.org/10.1182/blood.V114.22.2321.2321

Published: 2009

Journal Articles

Polish Myelodysplastic Syndromes Registry- Report of 15 Months of Activity.

Blood (2009) 114 (22): 4848.

https://doi.org/10.1182/blood.V114.22.4848.4848

Published: 2009

Journal Articles

Cladribine in Combination with Standard Daunorubicine and Cytarabine (DAC) as a Remission Induction Treatment Improves the Overall Survival in Untreated Adults with AML Aged < 60 y Contrary to Combination Including Fludarabine (DAF): A Multicenter, Randomized, Phase III PALG AML 1/2004 DAC/DAF/DA Study in 673 Patients-A Final Update.

Blood (2009) 114 (22): 2055.

https://doi.org/10.1182/blood.V114.22.2055.2055

Published: 2009

Journal Articles

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

Blood (2008) 112 (11): 4179.

https://doi.org/10.1182/blood.V112.11.4179.4179

Published: 2008

Journal Articles

The Impact of NOD2/CARD15, TLR and IL23R Polymorphisms on the Incidence of Infectious Complications in Allo-HSCT Recipients.

Alexandra Maria Holowiecka-Goral, Sebastian Giebel, Jerzy Wojnar, Elzbieta Pietruszka, Agnieszka Karolczyk, Anna Soja, Tomasz Czerw, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Wlodzimierz Mendrek, Beata Stella-Holowiecka, Slawomira Kyrcz-Krzemien

Blood (2008) 112 (11): 2201.

https://doi.org/10.1182/blood.V112.11.2201.2201

Published: 2008

Journal Articles

Addition of Cladribine to the Standard Daunorubicine - Cytarabine (DA 3+7) Remission Induction Protocol (DAC) Contrary to Adjunct of Fludarabine (DAF) Improves the Overall Survival in Untreated Adults with Acute Myeloid Leukemia Aged up to 60 Y: A Multicenter, Randomized, Phase III PALG AML 1/2004 DAF/DAC/DA Study in 673 Patients

Blood (2008) 112 (11): 133.

https://doi.org/10.1182/blood.V112.11.133.133

Published: 2008

Journal Articles

Survival Benefit of Post Induction Consolidation Therapy in MCL (Mantle Cell Lymphoma): a Polish Lymphoma Research Group (PLRG) Retrospective Multicenter Analysis

Wojciech Jurczak, Agnieszka Giza, Dorota Krochmalczyk, Dagmara Zimowska-Curylo, Marcin Sobocinski, Beata Stella-Holowiecka, Aleksandra Holowiecka-Goral, Piotr Boguradzki, Elzbieta Kisiel, Grzegorz Mazur, Tomasz Wrobel, Wanda Knopinska-Posluszny, Ewa Kalinka - Warzocha, Aleksander B. Skotnicki

Blood (2008) 112 (11): 4936.

https://doi.org/10.1182/blood.V112.11.4936.4936

Published: 2008

Journal Articles

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Blood (2008) 112 (11): 2103.

https://doi.org/10.1182/blood.V112.11.2103.2103

Published: 2008

Journal Articles

The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.

Jerzy Holowiecki, Sebastian Grosicki, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Andrzej Hellmann, MD, PhD, Agnieszka Wierzbowska, Marek Seweryn, Beata Stella-Holowiecka, Maria Sadus-Wojciechowska

Blood (2008) 112 (11): 1950.

https://doi.org/10.1182/blood.V112.11.1950.1950

Published: 2008

Journal Articles

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Jerzy Holowiecki, Sebastian Grosicki, MD, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, MD, Aleksander B. Skotnicki, Beata Jakubas, MD, Andrzej Hellmann, Tadeusz Robak, Marek J. Seweryn, MD, Beata Stella-Holowiecka, MD, Maria Sadus-Wojciechowska, MD

Blood (2007) 110 (11): 4375.

https://doi.org/10.1182/blood.V110.11.4375.4375

Published: 2007

Journal Articles

Minimal Residual Disease Status Is the Most Important Preditive Factor in Adults with Acute Lymphoblastic Leukemia. Prospective, Multicenter PALG 4-2002 MRD Study.

Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Sebastian Giebel, Krystyna Jagoda, Beata Stella-Holowiecka, Beata Jakubas, Monika Paluszewska, Ilona Seferynska, Anna Czyz, Wlodzimierz Mendrek, Aleksander Skotnicki, Wieslaw W. Jedrzejczak, Krzysztof Warzocha, Lech Konopka, Andrzej Hellmann

Blood (2007) 110 (11): 2821.

https://doi.org/10.1182/blood.V110.11.2821.2821

Published: 2007

Journal Articles

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

Jerzy Holowiecki Prof, Tomasz Czerw, MD, Jerzy Wojnar, MD, PhD, Malgorzata Krawczyk-Kulis, MD, PhD, Sebastian Grosicki, MD, Beata Stella-Holowiecka, MD, PhD, Slawomira Kyrcz-Krzemien Prof, Maria Sadus-Wojciechowska, MD, Sebastian Giebel, MD, Lucja Kachel, MD, Krzysztof Wozniczka, MD, Aleksandra Holowiecka-Goral, MD

Blood (2007) 110 (11): 2875.

https://doi.org/10.1182/blood.V110.11.2875.2875

Published: 2007

Journal Articles

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Blood (2007) 109 (9): 3672–3675.

https://doi.org/10.1182/blood-2006-08-042929

Published: 2007

Journal Articles

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Jerzy Wojnar, MD, Sebastian Giebel, MD, Miroslaw Markiewicz, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Beata Stella-Holowiecka, MD, Tomasz Kruzel, MD, Jerzy Holowiecki

Blood (2006) 108 (11): 5245.

https://doi.org/10.1182/blood.V108.11.5245.5245

Published: 2006

Journal Articles

Occurrence and Treatment of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Leukaemias: A Single Institute Experience with 442 Patients.

Dariusz Kata, MD, Jerzy Holowiecki, Jerzy Wojnar, MD, Beata Stella-Holowiecka, MD, Slawomira Krzemien, Krzysztof Wozniczka, MD, Grzegorz Helbig, MD

Blood (2006) 108 (11): 5337.

https://doi.org/10.1182/blood.V108.11.5337.5337

Published: 2006

NARROW

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Cladribine Alone and in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Long-Term Follow-up of the the Polish Adult Leukemia Group (PALG CLL2) Study,

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

Overall Survival (OS) Benefit of Rituximab Based Immunochemotherapy Followed by Post-Induction Treatment in Mantle Cell Lymphoma (MCL): a Retrospective Analysis of 279 Patients Treated by Polish Lymphoma Research Group (PLRG) Centers.

Status of Minimal Residual Disease Determines Outcome of Autologous HSCT in Adults with High-Risk Acute Lymphoblastic Leukemia.

Polish Myelodysplastic Syndromes Registry- Report of 15 Months of Activity.

Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine

The Impact of NOD2/CARD15, TLR and IL23R Polymorphisms on the Incidence of Infectious Complications in Allo-HSCT Recipients.

Survival Benefit of Post Induction Consolidation Therapy in MCL (Mantle Cell Lymphoma): a Polish Lymphoma Research Group (PLRG) Retrospective Multicenter Analysis

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

The Reduction of Leukemic Blasts In Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia: The Results of Multicenter, Prospective Polish Adult Leukemia Group Study.

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Minimal Residual Disease Status Is the Most Important Preditive Factor in Adults with Acute Lymphoblastic Leukemia. Prospective, Multicenter PALG 4-2002 MRD Study.

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Occurrence and Treatment of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Leukaemias: A Single Institute Experience with 442 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only